XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (Original PDF from Publisher)
$249.00 Original price was: $249.00.$25.00Current price is: $25.00.
Description
XARELTO Drug Profile, 2024 XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business
The following important facets of XARELTO are covered in this report:
United States patents
Expired US patents
Patent challenges under FDA Paragraph IV
District Court dispute pertaining to patents
Patent cases before the Patent Trial and Appeal Board (PTAB)
European certificates of supplemental protection (SPCs)
Clinical studies
The cost of drugs
Revenues from sales each year
Suppliers of finished goods
Sources of raw active pharmaceutical ingredients (APIs)
Additional information
Published Year |
2024 |
---|---|
Language |
English |
Publisher |
Other Publisher |
Edition |
1 st |
Format |
Publisher PDF |
File Size |
900 |
ISBN |
8875923647 |
Related Products
2-Deoxy-D-Glucose: Chemistry and Biology (Original PDF from Publisher)
Rated 0 out of 5
2012-2013 Top 300 Pharmacy Drug Cards (LANGE FlashCards)
Rated 0 out of 5
5 ed – First Aid for the USMLE Step 2 CS
Rated 0 out of 5
7th International Conference on Materials Sciences and Nanomaterials & 6th International Conference on Advanced Composite Materials (Original PDF from Publisher)
Rated 0 out of 5
A Guide to Vitamins and Their Effects on Diseases (Original PDF from Publisher)
Rated 0 out of 5
A Problem-Oriented Approach to Immunodeficiencies and Immune-Mediated Conditions in Horses, An Issue of Veterinary Clinics of North America: Equine Practice (True PDF from Publisher)
Rated 0 out of 5
A Radio-Pathologic Atlas of Breast Diseases (Original PDF from Publisher)
Rated 0 out of 5
A Review of Statistical Methods for Medical and Allied Health Professionals (Original PDF from Publisher)
Rated 0 out of 5
A Textbook of Neuroanatomy, 3rd edition (Original PDF from Publisher)
Rated 0 out of 5
Be the first to review “XARELTO Drug Profile, 2024: XARELTO (rivaroxaban) drug patents, FDA exclusivity, litigation, drug prices, sales revenues (DrugPatentWatch Business Intelligence Reports) (Original PDF from Publisher)” Cancel reply
Reviews
There are no reviews yet.